Biogen and Denali discontinue Parkinson's drug after trial fails

May 21, 2026 6:00 PM

Biogen Inc. (NASDAQ: BIIB) and Denali Therapeutics Inc. (NASDAQ: DNLI) announced that their experimental Parkinson's disease treatment BIIB122 failed to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found